Cargando…

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects

BACKGROUND: Antipsychotic-induced metabolic side effects are major concerns in psychopharmacology and clinical psychiatry. Their pathogenetic mechanisms are still not elucidated. METHODS: Herein, we review the impact of neurotransmitters on metabolic regulation, providing insights into antipsychotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siafis, Spyridon, Tzachanis, Dimitrios, Samara, Myrto, Papazisis, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187748/ https://www.ncbi.nlm.nih.gov/pubmed/28676017 http://dx.doi.org/10.2174/1570159X15666170630163616

Ejemplares similares

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

The Added Value of Liquid Antipsychotics: The Case of Quetiapine
por: Papazisis, Georgios, et al.
Publicado: (2019)

T200. METABOLIC SIDE EFFECTS OF ANTIPSYCHOTIC DRUGS – PROTOCOL OF A SYSTEMATIC REVIEW AND NETWORK- METAANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Nonmedical Use of Prescription Drugs among Medical Students and the Relationship With Illicit Drug, Tobacco, and Alcohol Use
por: Papazisis, Georgios, et al.
Publicado: (2018)

Prescribing Z-drugs in Greece: an analysis of the national prescription database from 2018 to 2021
por: Siafis, Spyridon, et al.
Publicado: (2023)

Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students
por: Filippiadou, Magdalini, et al.
Publicado: (2017)

Prevalence of Cannabis Use Among Medical Students: A Systematic Review and Meta-analysis
por: Papazisis, Georgios, et al.
Publicado: (2018)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

Assessment of the Safety Signal for the Abuse Potential of Pregabalin and Gabapentin Using the FAERS Database and Big Data Search Analytics
por: Papazisis, Georgios, et al.
Publicado: (2021)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
por: Schneider-Thoma, Johannes, et al.
Publicado: (2021)

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
por: Adkins, Daniel E., et al.
Publicado: (2010)

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Monitoring side-effects of antipsychotics using the glasgow antipsychotic side-effect scale
por: Sterritt, James
Publicado: (2021)

Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
por: Stamoula, Eleni, et al.
Publicado: (2021)

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis
por: Feber, Lena, et al.
Publicado: (2023)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
por: Sinkeviciute, Igne, et al.
Publicado: (2012)

Thermoregulation and Altered Calcium Signaling: A Side-Effect of Antipsychotic Drugs?
por: Anwer, Mohammad Osama, et al.
Publicado: (2014)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database
por: Bakirtzis, Christos, et al.
Publicado: (2020)

The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis
por: Zhang, Yangyu, et al.
Publicado: (2017)

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication
por: Wykes, T., et al.
Publicado: (2017)

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study
por: Hirsch, Lauren, et al.
Publicado: (2018)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio, Maria-Cristina, et al.
Publicado: (2017)

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
por: Rognoni, Carla, et al.
Publicado: (2021)

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine
por: Santarelli, Danielle M., et al.
Publicado: (2013)

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
por: Scigliano, Giulio, et al.
Publicado: (2013)

Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects
por: Wei Xin Chong, Joyce, et al.
Publicado: (2016)

Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting
por: Müller, Katharina, et al.
Publicado: (2023)

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D(2) receptors
por: Sykes, David A., et al.
Publicado: (2017)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

Clinical perspective on antipsychotic receptor binding affinities
por: Crapanzano, Calogero, et al.
Publicado: (2021)

Sex differences in antipsychotic efficacy and side effects in psychosis
por: Erzin, G.
Publicado: (2023)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
por: Yang, Ye, et al.
Publicado: (2022)

T231. QUALITY OF LIFE IN ANTIPSYCHOTIC-NAïVE YOUTH: EXPLORING THE INTERPLAY WITH METABOLIC SIDE-EFFECTS
por: Chintoh, Araba, et al.
Publicado: (2020)

Audit on the monitoring of metabolic side effects of antipsychotics in acute inpatient psychiatric units at Fieldhead Hospital
por: En Tial, Stephanie Vel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5fq5s10tjrbfp749br33enq6du